Agios Pharmaceuticals, Inc.

Healthcare

NASDAQ:AGIO · NASDAQ Global Select

Market Cap $1.97B Beta 0.59 P/E (TTM) -4.7

$34.16 +1.50%

+$0.50 today

52W Low $22.24High $46.00

Vol 1.78M · Avg 1.11M

EPS (TTM) -$7.19Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+2.46%

Period High

$45.49

Period Low

$22.34

Latest

$34.16

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

ImmunityBio, Inc.

NASDAQ:IBRX

$7.42B

Liquidia Corporation

NASDAQ:LQDA

$5.96B

Cogent Biosciences, Inc.

NASDAQ:COGT

$5.85B

Denali Therapeutics Inc.

NASDAQ:DNLI

$3.73B

Beam Therapeutics Inc.

NASDAQ:BEAM

$3.40B

Arcus Biosciences, Inc.

NYSE:RCUS

$2.41B

89bio, Inc.

ETNB

$2.20B

Galapagos N.V.

GLPG

$1.84B

Sarepta Therapeutics, Inc.

NASDAQ:SRPT

$1.81B

Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

$1.41B

What is the latest AGIO filing?

The latest filing shown is 4 dated Jun 16, 2026.

How many recent filings does AGIO have?

Intrinsic Alpha currently shows 20 recent filings for AGIO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.